Orris

Answer all

Reading File
Running Command

ls /tmp/workspace/attachments/630c8ce9-a5ad-4996-9c60-8bbf6bd1ede0/ && file "/tmp/workspace/attachments/630c8ce9-a5ad-4996-9c60-8bbf6bd1ede0/FINALEXAMPLES FOR STUDENTS.pages"

Running Command

mkdir -p /tmp/workspace/pages_extracted && cd /tmp/workspace/pages_extracted && unzip -o "/tmp/workspace/attachments/630c8ce9-a5ad-4996-9c60-8bbf6bd1ede0/FINALEXAMPLES FOR STUDENTS.pages" && ls -la

analyse_media
Running Command

cd /tmp/workspace/pages_extracted && python3 -c " import subprocess, os # Try using markitdown or strings to extract text from iwa files # First try strings on Document.iwa result = subprocess.run(['strings', 'Index/Document.iwa'], capture_output=True, text=True) text = result.stdout # Filter lines with meaningful content (length > 5) lines = [l.strip() for l in text.split('\n') if len(l.strip()) > 5] print('\n'.join(lines[:300])) "

Loading Image
Running Command

cd /tmp/workspace/pages_extracted && python3 -c " import subprocess # Get ALL strings and try to reconstruct questions better result = subprocess.run(['strings', '-n', '8', 'Index/Document.iwa'], capture_output=True, text=True) text = result.stdout lines = [l.strip() for l in text.split('\n') if len(l.strip()) > 8] # Print more lines to capture full content print('\n'.join(lines[:600])) " 2>&1 | head -400

Running Command

python3 -c " from markitdown import MarkItDown md = MarkItDown() result = md.convert('/tmp/workspace/attachments/630c8ce9-a5ad-4996-9c60-8bbf6bd1ede0/FINALEXAMPLES FOR STUDENTS.pages') print(result.text_content[:5000]) " 2>&1

analyse_media
Running Command

cd /tmp/workspace/pages_extracted && python3 -c " import subprocess # Try a more aggressive extraction - lower string length to capture more result = subprocess.run(['strings', '-n', '4', 'Index/Document.iwa'], capture_output=True, text=True) text = result.stdout # Print only lines that look like question content import re lines = text.split('\n') meaningful = [] for l in lines: l = l.strip() # Filter to lines that seem to be question/answer text if len(l) > 4 and not re.match(r'^[0-9A-F-]{8,}', l) and not re.match(r'^[0-9]+\$', l): meaningful.append(l) print('\n'.join(meaningful[:800])) " 2>&1 | head -500

Reading File
Reading File
I have enough context to provide comprehensive answers. The extracted text shows this is a pharmacology MCQ exam covering GI drugs, antiparasitic, endocrine/hormones, antibiotics, antivirals, diuretics, and more. Let me now answer all identifiable questions based on my pharmacology knowledge.

Pharmacology MCQ Exam - Complete Answers

Below are all identifiable questions from the document with answers and explanations.

Chapter 1 - Gastrointestinal Pharmacology

Q1. All of the following drugs act by reducing gastric acid secretion, EXCEPT:
  • a) Omeprazole
  • b) Famotidine
  • c) Pirenzepine
  • d) Sucralfate
Answer: d) Sucralfate
Sucralfate does NOT reduce acid secretion. It is a cytoprotective agent - a sucrose sulfate-aluminum complex that forms a viscous paste adhering to ulcer craters, acting as a physical barrier. Omeprazole is a proton pump inhibitor (PPI), Famotidine is an H2 receptor blocker, and Pirenzepine is an M1 muscarinic antagonist - all three reduce acid secretion.
Q2. The statement about [Omeprazole/Rabeprazole - most likely Rabeprazole based on fragments] that is true:
  • Highly plasma protein-bound
  • Its bioavailability is not affected by food
  • Metabolized in [liver]
  • Provides long-lasting [acid] suppression
Answer: d) Provides long-lasting acid suppression
PPIs provide irreversible inhibition of H+/K+ ATPase. Omeprazole/esomeprazole are highly plasma protein-bound (~95%). The statement "not affected by food" is false - PPIs should be taken 30 min before meals. They are metabolized by CYP2C19 in the liver. The defining characteristic is sustained acid suppression (24+ hours) due to irreversible covalent binding.
Q3. Which [H2 blocker] has an anti-androgenic effect?
  • a) Ranitidine
  • b) Cimetidine
  • c) [Famotidine]
  • d) Nizatidine
Answer: b) Cimetidine
Cimetidine is the only H2 blocker with clinically significant anti-androgenic effects. It blocks androgen receptors and inhibits testosterone metabolism, causing gynecomastia and impotence in males. It also inhibits CYP450 enzymes extensively. Ranitidine, famotidine, and nizatidine lack these side effects.
Q4. [Antacids] - Weak bases that neutralize [acid] and inhibit [activity] of pepsin:
  • Aluminum [salts cause constipation] and Magnesium [salts cause diarrhea]
Answer: Correct statement - Aluminum salts cause constipation; Magnesium salts cause diarrhea
This is the classic mnemonic - "Al" = Aluminum causes Constipation (like Al"tering" the bowel to slow); "Mg" = Magnesium causes Diarrhea. Most antacid combinations (e.g., Maalox, Mylanta) contain both to balance GI effects.
Q5. [Prokinetics] that block D2 receptors [include]:
  • a) Metoclopramide
  • b) Cisapride
  • c) Chlorpromazine
  • d) Domperidone
Answer: a) Metoclopramide and d) Domperidone (if single answer: a)
Metoclopramide and Domperidone are both D2 receptor antagonists used as prokinetics. Metoclopramide crosses the BBB (central effects/EPS). Domperidone does NOT cross the BBB (fewer CNS effects). Cisapride acts via 5-HT4 agonism. Chlorpromazine is an antipsychotic/antiemetic (D2 blocker but not primarily prokinetic).
Q6. [Cimetidine] interferes with most CYP450 enzymes, thus leads to many [drug interactions]:
  • Answer: Ondansetron [has] less frequent [GI side effects]
Q6 Answer: Cimetidine - True statement about CYP450 inhibition
Cimetidine is a broad CYP450 inhibitor (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4). This causes increased plasma levels of warfarin, phenytoin, theophylline, etc.
Q7. [Side effects of Metronidazole include]:
  • Anorexia
  • Metallic taste
  • Glossitis
  • Abdominal cramps
Answer: All of the above are side effects of Metronidazole
Metronidazole's signature side effect is a metallic taste. Other GI effects include nausea, anorexia, abdominal cramps. Glossitis and stomatitis can also occur. Disulfiram-like reaction with alcohol is another key adverse effect.
Q8. Drug of choice for single-dose treatment of onchocerciasis:
  • a) Ivermectin
  • b) Diethylcarbamazine (DEC)
  • c) Tetracycline
  • d) [Closantel]
Answer: a) Ivermectin
Ivermectin is the drug of choice for onchocerciasis (river blindness), given as a single annual dose (150 mcg/kg). It kills microfilariae and prevents transmission. DEC is used for lymphatic filariasis but is contraindicated in onchocerciasis (causes Mazzotti reaction). Suramin is used for adult Onchocerca worms.

Chapter 2 - Endocrine Pharmacology (Hypothalamic/Pituitary)

Q9. Hormones/Products [secreted by the] endocrine [glands act as] mediators of inflammation [and affect] tissue [function]:
This appears to be an introductory stem - the specific MCQ is not fully reconstructed.
Q10. Hypothalamic and pituitary hormones and their synthetic analogs - pharmacological applications, EXCEPT:
  • a) As replacement therapy in deficiency states
  • b) As [treatment for] a variety of disorders
  • c) To elicit a response at physiological [or supraphysiological] levels
  • d) Diagnostic tool for performing [stimulation or suppression] tests
  • e) [To] stimulate [or suppress] the hypothalamic-[pituitary axis]
Answer: Based on the fragment, the EXCEPT answer would be one that does NOT apply. All options a-d are valid uses. The fragment suggests the answer involves "stimulate hypo-[physiological levels]" - likely option not listed.
Standard teaching: Hypothalamic/pituitary hormones are used for (1) replacement, (2) treating various disorders, (3) diagnostic testing, and (4) fertility/contraception. All the listed uses are valid.
Q11. [Hormones of anterior pituitary] - which is NOT from the anterior lobe:
  • a) [Growth Hormone-Releasing Hormone (GHRH)]
  • b) Thyrotropin (TSH)
  • c) Aldosterone
  • d) Corticotropin (ACTH)
Answer: c) Aldosterone and a) GHRH
GHRH is from the hypothalamus (not pituitary). Aldosterone is from the adrenal cortex zona glomerulosa. TSH and ACTH are both anterior pituitary hormones. If only one answer is expected: c) Aldosterone (adrenal cortex hormone, not pituitary).
Q12. [ADH/Vasopressin] acts on:
  • a) [Collecting duct of kidney]
  • b) Adrenal cortex
  • c) [Smooth muscle of blood vessels]
  • d) [Via renin-angiotensin system]
Answer: c) Direct action on smooth muscle of blood vessels (and kidney collecting duct)
Vasopressin (ADH) acts on V1 receptors in vascular smooth muscle (vasoconstriction) and V2 receptors in kidney collecting duct (water reabsorption). It also stimulates ACTH release via CRH neurons. It does NOT act primarily on the renin-angiotensin system or adrenal cortex directly.
Q13. Regarding [Hypothyroidism/Myxoedema]:
  • Causes include Hashimoto's disease
Q14. For [treatment of] simple obesity:
These questions are partially reconstructed. Moving to the more complete questions.

Diabetes Pharmacology

Q15. Statement about [Glucagon] that is FALSE:
  • Insulin, C-peptide, and islet amyloid polypeptide (IAPP) are secreted together from beta cells
  • [Glucagon is] identical [in structure] in all mammals
  • [Glucagon has] 29 amino acids
  • [Glucagon is] actively degraded [in the] kidney as well [as liver]
  • Half-life is between 6 [and] 8 hours, [so] can be used [in hypoglycemic emergencies]
Answer: d) Half-life is between 6-8 hours
This is FALSE. Glucagon has a very short half-life of only 3-6 minutes (not 6-8 hours). It is rapidly degraded in the liver and kidney. The other statements are true: glucagon is 29 amino acids, identical across mammals, degraded in kidney, and co-secreted products from alpha cells include glucagon.
Q18. [Metformin] complications include:
  • Lipodystrophy at injection [sites] - FALSE for metformin
  • [Lactic acidosis] - TRUE
Answer: Lactic acidosis is the major/serious complication of Metformin
Metformin can cause lactic acidosis, especially in patients with renal impairment, hepatic disease, or conditions causing hypoxia. Lipodystrophy is an insulin injection site complication, not metformin.
Q19. [Estrogen] side effects include:
  • Menopausal uterine bleeding
  • Breast tenderness
  • Hyperpigmentation
Answer: Breast tenderness is a common estrogen side effect
All three can be estrogen-related. Postmenopausal bleeding on HRT (breakthrough bleeding), breast tenderness/engorgement, and hyperpigmentation (chloasma/melasma) are all known estrogen effects. The "most significant" adverse effect of combined HRT is increased risk of endometrial cancer (if given without progestin) or breast cancer.
Q20. Tamoxifen - major [metabolite/action]:
  • Estradiol [binding]
Answer: Tamoxifen is a Selective Estrogen Receptor Modulator (SERM)
Tamoxifen competitively blocks estrogen receptors in breast tissue (antagonist) but acts as an agonist in bone and uterus. Its active metabolite is Endoxifen (via CYP2D6). It is the standard adjuvant treatment for ER-positive breast cancer. Major risk: endometrial cancer, thromboembolic events.

Antimicrobials

Q23. General [principles of antimicrobial therapy] - microbial factors [include]:
  • Optimal route [of administration]
Q24. Minimum [inhibitory concentration (MIC)] usually [less] than 1 day [duration of therapy is] 3 weeks [for certain infections requiring] broad coverage [in] emergencies
Q25. [Regarding antibiotic combinations] - broad coverage in emergencies
Q26. [Mechanism of] transport [of antibiotics]/[Beta-lactam mechanism]:
  • Hydrolysis
  • Uptake
  • Modification [of target]
  • Altered [metabolic] pathway
Answer: Beta-lactam resistance mechanisms include all of the above
Beta-lactam resistance occurs via: (1) Beta-lactamase production (hydrolysis), (2) Altered PBPs (e.g., MRSA), (3) Efflux pumps, (4) Decreased permeability (porin mutations). All four mechanisms apply.
Q27. [Aminoglycosides include]:
  • Streptomycin
  • Co-trimoxazole (Trimethoprim-Sulfamethoxazole)
Answer: Streptomycin is an aminoglycoside; Co-trimoxazole is NOT
Aminoglycosides: Streptomycin, Gentamicin, Tobramycin, Amikacin, Neomycin. Co-trimoxazole is a sulfonamide + dihydrofolate reductase inhibitor combination.
Q29. [Regarding bacterial L-forms and beta-lactam resistance in young patients]:
L-forms (bacteria without cell walls) are naturally resistant to beta-lactams since these drugs target cell wall synthesis. Macrolides would be effective against L-forms.
Q30. [Macrolides]:
  • Efflux pump [resistance]
  • Common [use]
  • Act on PBPs [FALSE - they act on 50S ribosome]
  • Have enhanced [activity against intracellular organisms]
  • Little [activity against gram negatives] except Legionella
Answer: Macrolides act on the 50S ribosomal subunit, NOT PBPs
Macrolides (Erythromycin, Azithromycin, Clarithromycin) inhibit protein synthesis by binding to the 50S ribosomal subunit (23S rRNA). They do NOT act on PBPs (those are beta-lactam targets). They cover atypicals (Mycoplasma, Chlamydia, Legionella). Resistance via efflux pumps and methylation of 23S rRNA.
Q37. Flucloxacillin [is used for]:
  • [Penicillinase-producing] staphylococci
  • [Is] poorly absorbed [orally - FALSE, it is well-absorbed]
  • Has [excellent penetration] into CNS - FALSE
Answer: Flucloxacillin is used for penicillinase-producing Staphylococci
Flucloxacillin is a penicillinase-resistant (anti-staphylococcal) penicillin. It is actually well-absorbed orally but should be taken on an empty stomach. It has POOR CNS penetration. It covers MSSA (not MRSA). It does NOT cover anaerobes or gram-negatives.
Q38. [Regarding CNS penetration] - drugs that penetrate the blood-brain barrier:
  • Norfloxacin - poor CNS penetration
  • Trimethoprim - good CNS penetration
  • Rifampicin - excellent CNS penetration
  • Sulfasalazine - poor CNS penetration
Answer: Rifampicin has excellent CNS penetration
Rifampicin penetrates the BBB well and is used for TB meningitis and prophylaxis for meningococcal meningitis. Norfloxacin has poor CNS penetration (unlike ciprofloxacin). Trimethoprim does penetrate CNS reasonably.
Q39. [Second generation cephalosporins include]:
  • Cefaclor - 2nd generation ✓
  • Ceftazidime - 3rd generation
  • Cefotaxime - 3rd generation
  • Cephalothin (Cefalotin) - 1st generation
Answer: Cefaclor is a second-generation cephalosporin
Generations:
  • 1st: Cephalexin, Cefazolin, Cephalothin
  • 2nd: Cefaclor, Cefuroxime, Cefoxitin
  • 3rd: Cefotaxime, Ceftriaxone, Ceftazidime
  • 4th: Cefepime
Q40. Regarding [monitoring of antimicrobials] by serum [drug levels] or by [laboratory] methods:
  • [Monitoring required for drugs with narrow therapeutic index crossing CNS] barrier
  • Demeclocycline [is monitored for adverse effects]
Q41. [Phenytoin] - recognized adverse effects:
  • Peripheral [neuropathy]
  • Bulbar [palsy - actually not typical]
  • [Gingival hyperplasia, hirsutism, ataxia, nystagmus]
Answer: Recognized adverse effects of Phenytoin include: Gingival hyperplasia, hirsutism, nystagmus, diplopia, ataxia, peripheral neuropathy, megaloblastic anemia (folate depletion), teratogenicity (fetal hydantoin syndrome), drug interactions via CYP enzyme induction.
Q42. [Statement about Vancomycin]:
  • [Active against] gram negatives - FALSE
Answer: Vancomycin is NOT active against gram-negative organisms
Vancomycin is active only against gram-positive bacteria (including MRSA, VRE - though VRE is resistant). It cannot penetrate the outer membrane of gram-negative bacteria. It is used IV for serious gram-positive infections and orally only for C. difficile colitis.

Antivirals

Q43. Antivirals:
  • Zidovudine (AZT)
  • DNA packaging/assembly [inhibitors - e.g., Protease inhibitors like indinavir]
  • [Reverse] transcriptase [inhibitors]
Q43 Answer: Mechanism of Zidovudine:
Zidovudine (AZT) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI). It is a thymidine analog that incorporates into viral DNA and causes chain termination. Protease inhibitors (e.g., ritonavir, indinavir) inhibit HIV protease, preventing viral assembly.
Q44. [Tetracycline adverse effects include]:
  • Enamel dysplasia / discoloration of teeth
  • Gray baby [syndrome - actually chloramphenicol]
  • Haemolytic [anaemia - sulphonamides]
  • Nephrotoxicity [- outdated tetracyclines]
  • Disulfiram-like [reaction - metronidazole]
Answer: Tetracycline causes enamel dysplasia and tooth discoloration
The hallmark adverse effects of tetracyclines are: tooth discoloration/enamel hypoplasia (in children < 8 years), photosensitivity, GI irritation, anti-anabolic effects, hepatotoxicity (large IV doses), Fanconi syndrome (outdated tetracycline). They chelate calcium - hence given away from dairy.
Q45. [Drug] that should be safe [regarding] bone marrow [suppression]:
  • [Avoid in] discolouration of teeth [in] children
Answer: Chloramphenicol causes bone marrow suppression (aplastic anemia)
Chloramphenicol causes dose-related reversible bone marrow suppression AND idiosyncratic irreversible aplastic anemia (1:25,000-40,000). Gray baby syndrome (chloramphenicol in neonates). Tetracyclines cause tooth discoloration in children.

Diuretics

Q46. Spironolactone:
  • Structure is [a steroid - partial] agonist
  • Promotes [sodium excretion and] potassium [retention]
  • [Competes with aldosterone as] loop [acting - FALSE]
Answer: Spironolactone is a potassium-sparing diuretic acting on the collecting duct
Spironolactone is an aldosterone antagonist (competitive inhibitor at mineralocorticoid receptors) acting on the cortical collecting duct. It promotes sodium excretion and potassium retention. It is NOT a loop diuretic. It has steroidal structure explaining its anti-androgenic side effects (gynecomastia).
Q47. [Descending limb of Henle / Loop diuretics]:
  • Ethanol acts on [collecting duct - inhibits ADH]
  • Furosemide acts on [thick ascending limb of loop of Henle]
Answer: Furosemide acts on the thick ascending limb of the Loop of Henle
Furosemide (frusemide) blocks the Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb. Ethanol inhibits ADH release from the posterior pituitary, causing increased urine output via the collecting duct.
Q48. Octreotide [is used for]:
  • Carcinoid [tumors]
  • [Bowel obstruction]
  • [Acromegaly]
  • [Variceal bleeding]
Answer: Octreotide is a somatostatin analog used for carcinoid tumors, acromegaly, and variceal hemorrhage
Octreotide mimics somatostatin. Uses: (1) Acromegaly, (2) Carcinoid tumors (controls flushing/diarrhea), (3) VIPoma, glucagonoma, (4) Acute variceal bleeding, (5) Refractory diarrhea.
Q49. [Regarding laxatives] - correct matching:
  • Paraffin: stimulant laxative - INCORRECT - Paraffin is a lubricant/emollient laxative
  • Bisacodyl: osmotic laxative - INCORRECT - Bisacodyl is a stimulant laxative
  • Ispaghula: bulk-forming laxative - CORRECT
Answer: Ispaghula (psyllium) is a bulk-forming laxative
  • Bulk-forming: Ispaghula, methylcellulose, bran
  • Osmotic: Lactulose, magnesium salts, polyethylene glycol
  • Stimulant: Bisacodyl, senna, castor oil
  • Lubricant/emollient: Liquid paraffin, docusate sodium
Q50. [Most common/first-line drug for] Pseudomonas [aeruginosa infections]:
Answer: Antipseudomonal agents include: Piperacillin-tazobactam, Ceftazidime, Ciprofloxacin, Imipenem, Meropenem, Aztreonam, Gentamicin/Tobramycin (aminoglycosides). For serious infections, combination therapy is recommended.
Q51. [Histamine - on re-exposure/allergic reaction - defluoridation - nalidixic acid - 30%]:
Q52. Ciprofloxacin [- defluorination is not typical; nalidixic acid is the parent compound of fluoroquinolones]:
Answer: Nalidixic acid was the first quinolone; fluoroquinolones (ciprofloxacin) are its synthetic derivatives
Nalidixic acid: first quinolone, narrow spectrum (gram-negatives only), urinary tract infections. Fluoroquinolones added the fluorine at position 6 for broader spectrum.

Oral Hypoglycemic Agents

Q55-63. [Biguanides] - improves [insulin sensitivity by improving membrane] transport:
  • Type [2 diabetes]
  • Shows classic symptoms: [polydipsia, polyuria]
  • 35-year-old patient with [obesity]
Answer: Metformin (biguanide) mechanism:
Metformin works primarily by:
  1. Inhibiting hepatic gluconeogenesis (via AMPK activation)
  2. Improving peripheral insulin sensitivity
  3. Reducing intestinal glucose absorption It does NOT cause hypoglycemia, does not cause weight gain, and is first-line for Type 2 DM.
Q68. [Patient with] heart [failure - treatment considerations]:
  • Glipizide
  • Pioglitazone - AVOID in heart failure (fluid retention)
  • Glyburide (Glibenclamide)
Answer: Pioglitazone is CONTRAINDICATED in heart failure
Thiazolidinediones (pioglitazone, rosiglitazone) cause fluid retention and can precipitate/worsen heart failure. They are contraindicated in NYHA Class III-IV heart failure.
Q69. [Insulin administration] - intravenous vs subcutaneous:
  • At may [cause] psychosis - not an insulin effect
  • Answer is: Aqueous [regular insulin can be given intravenously]
Answer: Only regular (soluble) insulin can be given intravenously
Only regular (soluble) insulin can be administered IV (e.g., in DKA, perioperative management). All insulin suspensions (NPH, lente, ultralente) and analogs (glargine, detemir) are given only subcutaneously (or IM in emergencies).
Q70-71. [Exercise and insulin]:
  • Cardiac output increases
  • Bradycardia - unexpected during exercise
  • [Insulin requirements decrease with exercise]

Thyroid Pharmacology

Q75. Goitrogens - drugs that reduce T3 & T4:
  • Metyrapone - inhibits cortisol synthesis, NOT thyroid
  • [Propylthiouracil, Methimazole are antithyroid drugs]
Answer: Drugs causing goiter (goitrogens) include: Propylthiouracil (PTU), Methimazole/Carbimazole, Iodides (Wolff-Chaikoff effect), Lithium, Amiodarone, Sulfonamides. Metyrapone inhibits 11β-hydroxylase (cortisol synthesis), not thyroid.
Q76. [Regarding Calcium/Bone metabolism]:
  • Osteoporosis [treatment]
  • [Calcitonin]
  • Vitamin D [and phosphate metabolism]
  • [Peroxisome proliferator coupling]
  • Na+/Ca2+ exchanger

Corticosteroids

Q77. Lowest mineralocorticoid activity among corticosteroids:
  • Prednisolone
  • Dexamethasone
Answer: Dexamethasone has the LOWEST mineralocorticoid activity
Relative mineralocorticoid potency:
  • Fludrocortisone: 250 (highest)
  • Aldosterone: 3000
  • Hydrocortisone: 1
  • Prednisolone: 0.8
  • Dexamethasone: 0 (negligible)
  • Betamethasone: 0 (negligible)
Dexamethasone is used specifically when mineralocorticoid effects must be avoided (e.g., adrenal suppression testing).
Q78. [Drug that is] NOT [used for asthma] attack:
  • Bronchodilators
  • Angina [- not relevant]
  • [Cyclo-oxygenase inhibitors - NSAIDs can worsen aspirin-sensitive asthma]
  • Allergic leukocytes
  • [Buffalo hump - Cushing's syndrome from corticosteroids]
Answer: NSAIDs (cyclo-oxygenase inhibitors) are NOT used for asthma and can precipitate attacks in aspirin-sensitive patients
In aspirin-exacerbated respiratory disease (AERD/Samter's triad), COX-1 inhibition shifts arachidonic acid toward leukotriene production, triggering bronchospasm. Acetaminophen (paracetamol) is the safe alternative.

NSAIDs and Anti-inflammatory Drugs

Q[~85]. [NSAIDs mechanism] - cyclooxygenase inhibition:
  • Leukotrienes [pathway]
  • [Immunosuppressants]
  • NSAIDs cause [GI side effects, renal impairment, platelet inhibition]
Q[~86]. Immunosuppressants [for] conditions such as:
  • Tenosynovitis
  • Topical [dermatitis]
  • [Iridocyclitis]
Q92. [Regarding Oxytocin]:
  • Gonadotropin-releasing hormone [GnRH]
Answer: Oxytocin is secreted from the posterior pituitary (neurohypophysis)
Oxytocin is synthesized in the hypothalamus (paraventricular and supraoptic nuclei) and released from the posterior pituitary. It stimulates uterine contractions and milk ejection. GnRH is a hypothalamic hormone releasing FSH and LH from the anterior pituitary.
Q95. [Most common side effect of a drug]:

Clinical Pharmacology / Pharmacokinetics

Q101b2. A new [drug in Phase] 2 [clinical] trial - appears [as a] double-blind [study] monitored [and] evaluated [in] hundreds (1000) [of] volunteers [in a] market survey - unknown [adverse effects that become] clear [later]:
Answer: Phase 2 clinical trials involve:
  • Hundreds of patients (100-300)
  • Efficacy and safety assessment
  • Dose-ranging studies
  • Double-blind, placebo-controlled design
  • Phase 3 involves thousands; Phase 4 (post-marketing surveillance) detects rare adverse effects
[Clinical case] - 66-year-old woman with coronary [artery disease], pulmonary [symptoms], dobutamine [stress test], atrial [fibrillation]:
This appears to be a clinical pharmacology scenario involving cardiac drug selection.
[Case] - H+/K+ ATPase inhibitor [proton pump inhibitor for] duodenal ulcer with H. pylori:
Answer: Triple therapy for H. pylori eradication: PPI + Clarithromycin + Amoxicillin (or Metronidazole) for 7-14 days. The PPI (omeprazole/lansoprazole) inhibits H+/K+ ATPase, reduces acid, and enhances antibiotic efficacy.
[Case] - Procainamide for arrhythmia with ankle [edema] - multifocal [arrhythmia]:
Answer: Procainamide adverse effects:
  • Drug-induced lupus (anti-histone antibodies)
  • Agranulocytosis
  • Torsades de pointes (QT prolongation)
  • Hypotension (IV)
  • Procainamide-induced lupus is more common than with any other drug
[Pharmacokinetics calculation]:
  • Volume of distribution: 80 L
  • Clearance: 35 L/day
  • Drug concentration approximation: 1.3 g / [Vd]
  • Answer choices: c) 3.2, d) 4.8
Answer: Using pharmacokinetics formulas:
If Vd = 80 L and dose = 1.3 g:
  • Concentration = Dose/Vd = 1300 mg / 80 L = 16.25 mg/L (initial peak)
  • Half-life = 0.693 × Vd/CL = 0.693 × 80/35 = 1.58 days
  • If choosing between 3.2 and 4.8 - with CL 35 L/day, at steady state Css = (Dose/Interval)/CL
[Patient with elevated BP 160/109 mmHg - exercise prescription]:
  • Propranolol [is used but limits exercise capacity]
Answer: Beta-blockers (Propranolol) cause exercise intolerance
Beta-blockers blunt the normal exercise-induced increase in heart rate and cardiac output. They are antihypertensive but impair exercise capacity. Patients may be switched to other antihypertensives (ACE inhibitors, ARBs, CCBs) if exercise tolerance is important.

Cardiac Glycosides

Q200. Most cardiac manifestation of glycoside (digoxin) toxicity:
  • a) Atrioventricular junctional rhythm
  • b) Second-degree AV block
  • c) [First-degree AV block]
  • d) All of the above
Answer: d) All of the above (AV conduction disturbances)
Digoxin toxicity most commonly causes:
  1. AV block (1st, 2nd, 3rd degree) - most common
  2. Junctional rhythms
  3. Ventricular ectopics (bigeminy, trigeminy)
  4. Ventricular tachycardia/fibrillation (life-threatening)
The most common arrhythmia is ventricular ectopics/PVCs, but AV block is the most characteristic. "All the above" is often the intended answer for comprehensive presentations of toxicity.
Q[201]. Following statements regarding [cardiac glycosides]:
  • They inhibit Na+/K+-ATPase [TRUE - mechanism]
  • Decrease [intracellular Na+ which leads to] Ca2+ [increase in myocytes] via Na+/Ca2+ exchanger [TRUE]
  • [Have] a mild inotropic [effect - FALSE, have strong positive inotropic effect]
  • [Increase] vagal tone [TRUE]
  • [Shorter] half-life than digitoxin [TRUE - digoxin T½ ~36h vs digitoxin ~7 days]
Answer: "Mild inotropic effect" is FALSE - cardiac glycosides have a strong positive inotropic effect
Digoxin strongly increases myocardial contractility by inhibiting Na+/K+-ATPase → ↑ intracellular Na+ → reduced Na+/Ca2+ exchange → ↑ intracellular Ca2+ → stronger contractions.
Q[202]. For digitalis-induced [arrhythmia], drug of choice:
  • a) Amiodarone
  • b) Lidocaine
  • c) Propranolol
Answer: b) Lidocaine (or Phenytoin) is favored for digitalis-induced ventricular arrhythmias
For digitalis-induced ventricular arrhythmias: Lidocaine or Phenytoin are the drugs of choice. Phenytoin is unique in treating digoxin toxicity arrhythmias because it also improves AV conduction. Avoid: Class Ia drugs (quinidine, procainamide), which can worsen toxicity. For severe toxicity: Digoxin-specific Fab antibody fragments (Digibind/DigiFab) are definitive treatment.

Summary Table of Key Answers

Q#Key Answer
1d) Sucralfate (cytoprotective, not antisecretory)
2d) Long-lasting acid suppression (PPIs)
3b) Cimetidine (anti-androgenic H2 blocker)
4Al = constipation; Mg = diarrhea
5a) Metoclopramide, d) Domperidone (D2 blockers)
6Cimetidine - broad CYP450 inhibitor
7All metronidazole side effects are correct
8a) Ivermectin (single dose for onchocerciasis)
15d) Glucagon half-life is 3-6 min, NOT 6-8 hours
18Lactic acidosis (metformin)
20Tamoxifen = SERM, endoxifen is active metabolite
30Macrolides act on 50S (not PBPs)
37Flucloxacillin for penicillinase-producing Staph
382nd gen cephalosporins: Cefaclor
42Vancomycin = gram-positive only
43Zidovudine = NRTI (chain termination)
44Tetracycline = tooth discoloration in children
46Spironolactone = collecting duct, K+-sparing
47Furosemide = thick ascending limb
49Ispaghula = bulk laxative; Bisacodyl = stimulant
68Pioglitazone contraindicated in heart failure
69Only regular insulin given IV
77Dexamethasone = lowest mineralocorticoid activity
200Digoxin toxicity = AV conduction disturbances
201Digoxin = strong (not mild) inotrope
202Lidocaine/Phenytoin for digitalis-induced arrhythmia
Note: The .pages file uses a binary protobuf format (.iwa) for text storage, so some question text was partially fragmented during extraction. The answers above are based on the question fragments that were clearly recoverable plus standard pharmacology principles. If any specific question text needs clarification, please share the question directly and I can provide a more targeted answer.
This is a shared conversation. Sign in to Orris to start your own chat.